- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02661945
Usefulness of Near-focus With Narrow-band Imaging
May 31, 2019 updated by: Jung-Wook Kim, Kyunghee University Medical Center
Usefulness of Near-focus With Narrow-band Imaging for Determining Gastric Tumor Margin
Near-focus with narrow-band imaging is a novel technique to improve the quality of images of the irregular mucosal structures and microvessels of gastric neoplasms.
The investigators compare this technique with indio carmin spray, commonly used tool to determine tumor margin.
The subject are patients who underwent endoscopic submucosal dissection for gastric neoplasms.
Participants are randomized into near-focus with narrow-band imaging and indigo carmin groups.
First, marking is performed at the tumor margins determined by each modality.
The distance from the marking dots to the tumor margin is measured histopathologically in the resected specimens.
Finally, the investigators will compare the accuracy between two groups based on the distance from marking dots to tumor margin measured by histopathologic examination.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
444
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Incheon, Korea, Republic of
- Inha University School of Medicine
-
Pusan, Korea, Republic of
- Pusan National University School of Medicine
-
Seoul, Korea, Republic of, 130-872
- Kyung Hee University Hospital
-
Seoul, Korea, Republic of
- Severance Hospital, Yonsei University College of Medicine
-
Seoul, Korea, Republic of
- Soonchunhyang University Hospital
-
-
Chungcheongnam-do
-
Cheonan, Chungcheongnam-do, Korea, Republic of
- Cheonan Hospital, Soonchunhyang University College of Medicine
-
-
Seongbuk-gu
-
Seoul, Seongbuk-gu, Korea, Republic of, 02841
- Korea University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants who undergo endoscopic submucosal dissection for gastric tumors (early gastric carcinoma or gastric adenoma)
Exclusion Criteria:
- fail to en bloc resection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Near focus with narrow band imaging
Near focus with narrow band imaging is used for marking the tumor margin.
|
|
No Intervention: Indigo carmin
After indigo carmine was sprayed over the lesion, marking is performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accuracy (accurate if the distance (between margin dots and tumor margin measured by histopathology) was less than 1 mm)
Time Frame: 1 week after procedure
|
Marking was diagnosed as accurate if the distance (between margin dots and tumor margin measured by histopathology) was less than 1 mm
|
1 week after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nagahama T, Yao K, Maki S, Yasaka M, Takaki Y, Matsui T, Tanabe H, Iwashita A, Ota A. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc. 2011 Dec;74(6):1259-67. doi: 10.1016/j.gie.2011.09.005.
- Kiyotoki S, Nishikawa J, Satake M, Fukagawa Y, Shirai Y, Hamabe K, Saito M, Okamoto T, Sakaida I. Usefulness of magnifying endoscopy with narrow-band imaging for determining gastric tumor margin. J Gastroenterol Hepatol. 2010 Oct;25(10):1636-41. doi: 10.1111/j.1440-1746.2010.06379.x.
- Kim JW, Jung Y, Jang JY, Kim GH, Bang BW, Park JC, Choi HS, Cho JH; Research Group for Endoscopic Instruments and Stents of Korean Society of Gastrointestinal Endoscopy. Narrowband imaging with near-focus magnification for discriminating the gastric tumor margin before endoscopic resection: A prospective randomized multicenter trial. J Gastroenterol Hepatol. 2020 Nov;35(11):1930-1937. doi: 10.1111/jgh.15109. Epub 2020 Jun 16.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2015
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
January 20, 2016
First Submitted That Met QC Criteria
January 22, 2016
First Posted (Estimate)
January 25, 2016
Study Record Updates
Last Update Posted (Actual)
June 4, 2019
Last Update Submitted That Met QC Criteria
May 31, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NFNBI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Tumors
-
First Affiliated Hospital Xi'an Jiaotong UniversityAir Force Military Medical University, ChinaUnknown
-
Shandong UniversityCompletedGastric Subepithelial TumorsChina
-
AHS Cancer Control AlbertaTerminated
-
Western Sydney Local Health DistrictRecruitingGastric Cancer | Esophageal Neoplasms | Neuroendocrine Tumors | Gastric Adenocarcinoma | Cancer of Stomach | Oesophageal Cancer | Gastric Neoplasm | GIST | GI CancerAustralia
-
Eisai Inc.Quintiles, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Previously Untreated Gastric CancerUnited States, Russian Federation, United Kingdom, Ukraine
-
Chimeric TherapeuticsNot yet recruitingGastric Cancer | Colorectal Cancer | Neuroendocrine Tumors
-
Peking Union Medical College HospitalUnknown
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedGastric Cancer | Pancreatic CancerUnited States
-
Samsung Medical CenterActive, not recruitingGastric Adenocarcinoma | Malignant MelanomaKorea, Republic of
Clinical Trials on Near focus with narrow band imaging
-
King's College Hospital NHS TrustOlympusCompletedCeliac DiseaseUnited Kingdom
-
Michael WallaceOlympus America, Inc.CompletedPost-endoscopic Mucosal Resection of Colon PolypsUnited States
-
Kyunghee University Medical CenterUnknownHelicobacter Pylori InfectionKorea, Republic of
-
Mercy Medical CenterAdvocate Lutheran General Hospital; Olympus America, Inc.CompletedEndometriosisUnited States
-
Chinese University of Hong KongUnknownNasopharyngeal Carcinoma
-
Yonsei UniversityUnknownEarly Gastric Cancer | Gastric Dysplasia | Gastric Adenoma
-
Lotung Poh-Ai HospitalTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Lung Cancer | Endometrial Cancer | Peritoneal Cancer | Esophageal Carcinoma | Pancreatic Carcinoma | Gastrointestinal CarcinomaUnited States
-
London North West Healthcare NHS TrustUnknown